Previous 10 | Next 10 |
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 5.1% to $11.44 on volume of 198,678,404 shares Trio Petroleum Corp. (TPET) rose 22.1% to $0.63 on volume of 179,140,668 shares Soligenix Inc. (SNGX) rose 21.7% to $0.47 on volume of 133,754,026 shares Sup...
2024-04-15 12:47:11 ET More on Mid-day movers & stocks. Enlivex stock plunges 50% on mixed results from sepsis study WiSA Technologies to effect 1-for-150 reverse stock split Seeking Alpha’s Quant Rating on BioSig Technologies, Inc. Historical earn...
2024-04-15 10:13:02 ET Soligenix ( SNGX ) stock soared 106% in early trading Monday after the company said it received orphan drug designation from the FDA for the active ingredient in its Marburg vaccine, MarVax.... Read the full article on Seeking Alpha For further details...
A look at the top 10 most actives in the United States Soligenix Inc. (SNGX) rose 127.5% to $0.8782 on volume of 62,157,057 shares Trio Petroleum Corp. (TPET) rose 8.0% to $0.5571 on volume of 48,902,033 shares Organovo Holdings Inc. (ONVO) rose 36.3% to $1.3769 on volume of 34,819,187 sh...
2024-04-15 08:01:00 ET DENVER, Colo., Apr 15, 2024 ( 247marketnews.com )- Soligenix, Inc. (NASDAQ: SNGX ) stated that the United States Food and Drug Administration’s Office of Orphan Products Development granted orphan drug designation to the active ingredient in MarVax, the...
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection PR Newswire Provides MarVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON...
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection PR Newswire Provides SuVax™ Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON...
Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency PR Newswire Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Stati...
2024-03-15 13:53:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soligenix (NASDAQ: SNGX ) just reported results for the fourth quarter of 2023. Soligenix reported earnings per share of -6 cents. This was above the analyst estimate for ...
2024-03-15 07:35:53 ET More on Soligenix Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix Read the full article on Seeking Alpha For further details see: Soligenix GAAP EPS...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte...